Summit Wealth Group (Colorado)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.67M Buy
2,222
+183
+9% +$187K 0.22% 57
2026
Q1
$1.88M Buy
2,039
+101
+5% +$102K 0.2% 68
2025
Q4
$2.08M Buy
+1,938
New +$1.85M 0.28% 53
2025
Q3
Sell
-774
Closed -$603K 382
2025
Q2
$603K Buy
+774
New +$601K 0.15% 118

Other funds holding LLY

Summit Wealth Group (Colorado)'s LLY Position: Q2 2026 in Review

Summit Wealth Group (Colorado) increased its Eli Lilly (LLY) stake by 9% in Q2 2026, buying an estimated $187K and bringing the position to 2,222 shares worth $2.67M. The position accounts for 0.22% of the portfolio, ranked #57.

Summit Wealth Group (Colorado) first reported a position in LLY in Q2 2025 and has held it in 4 quarters since. 2,015 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Summit Wealth Group (Colorado) held 2,222 shares of Eli Lilly worth $2.67M as of Q2 2026.
  • Summit Wealth Group (Colorado) bought 183 Eli Lilly shares in Q2 2026, an estimated $187K.
  • Eli Lilly made up 0.22% of Summit Wealth Group (Colorado)'s portfolio in Q2 2026, its #57 holding.
  • Summit Wealth Group (Colorado) first reported a position in Eli Lilly in Q2 2025 and has held it in 4 quarters since.
  • 2,015 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Summit Wealth Group (Colorado)'s 13F filing for Q2 2026, filed 28 Jul 2026.